FLT3 (FLK2 or STK1 or CD135) Antibody - Western Blot Validated

Scientific Overview

Build reproducible readouts by using this antibody to evaluate FLT3 (FLK2) across matched sample sets. FLT3 is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Use matched handling so differences reflect biology rather than processing.

Following FLT3 across perturbations can help separate expression effects from compartment shifts.

Research Relevance

Perturbations such as inhibitors or ligand stimulation can drive rapid shifts in localization or complex formation. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood.

When building a narrative around the target, it helps to track:

• condition-to-condition comparisons with matched controls
• interaction patterns within multi-protein complexes
• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus

Application-Specific Context

This denaturing-format version is geared toward targets presented after reduction and denaturation, where epitope exposure can shift from native conformations. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. A short pilot series can help set exposure ranges and reduce reruns.

If your study spans multiple model systems, it can help to define a shared reference condition for FLT3 so cross-sample contrasts stay meaningful.

Pair this denaturing-format format with stable controls to keep FLT3 (FLK2) measurements coherent over time.